Cell type specific role of the stress response gene Immediate Early Response-3 (IER3) in intestinal inflammationand carcinogenesis
Cell type specific role of the stress response gene Immediate Early Response-3 (IER3) in intestinal inflammationand carcinogenesis
批准号:
253375373
负责人:
Professor Dr. Alexander Arlt
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2014
资助国家:
德国
项目状态:
已结题
起止时间:
2013-12-31 至 2020-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The stress response gene Immediate Early Response-3 (IER3) has a dual role in inflammation and tumorigenesis. In epithelial and epithelial cell-derived tumor cells, IER3 exerts a proapoptotic activity whereas it inhibits apoptosis in immune cells and haematologic tumor cells. This dual mode of action is due to a differential regulation of essential pathways governing cell survival, such as NF-kappaB, ERK- and PI3K/Akt. Recent studies with constitutive ier3 knock out mice confirmed this divergent role of IER3 in inflammatory diseases, e.g. in Dextran-Sodium-Sulfate (DSS) colitis and colitis associated carcinogenesis (CAC). To someextent, a yet undefined function of IER3 in tissue macrophages and T-lymphocytes may be responsible for the discrepant effects in the mouse models used so far. Addressing the high complexicity of the IER3 effects in the pathophysiology of gut inflammation and carcinogenesis, conditional knock-out mice exhibiting an ablated ier3 expression in enterocytes, myeloid cells (in particular macrophages) and CD4+ T-cells (in particular Th17-cells) will be used for the established DSS and azoxymethan (AOM)/DSS in vivo models for chronic colitis and CAC, respectively. These experiments allow detailed insights into the physiological role of IER3 in the epithelial as well as in the leucocytic compartment with respect to intestinal inflammation and epithelial stress adapation. Thereby, our study will substantially improve the understanding of the functions of IER3 as immune modulator and tumorsuppressor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CCL20 mediated onco-immuno-crosstalk in pancreatic cancer – translational intervention studies
-
批准号:414216991
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Professor Dr. Alexander Arlt
-
依托单位:
Die Rolle des IEX-1 (immediate early response gene X-1) im Pankreaskarzinom
-
批准号:202771748
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Professor Dr. Alexander Arlt
-
依托单位:
p53 induzierte Apoptose - Bedeutung transkriptionsunabhängiger und -abhängiger Mechanismen
-
批准号:5453043
-
项目类别:Research Fellowships
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:Professor Dr. Alexander Arlt
-
依托单位:
国内基金
海外基金
登录
查看更多内容
铋基邻近双金属位点Type B异质结光热催化合成氨机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:黎景卫
-
依托单位:
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
-
批准号:82371721
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王星云
-
依托单位:
GPSM1介导Ca2+循环-II型肌球蛋白网络调控脂肪产热及代谢稳态的机制研究
-
批准号:82370879
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:严婧
-
依托单位:
二型聚合函数基于扩展原理的构造与表示问题
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张炜
-
依托单位:
真菌中I型-III型聚酮杂合类天然产物的基因组挖掘
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:孔德坤
-
依托单位:
智能型Type-I光敏分子构效设计及其抗耐药性感染研究
-
批准号:22207024
-
项目类别:青年科学基金项目(C类)
-
资助金额:20.0万元
-
批准年份:2022
-
负责人:赵琦
-
依托单位:
TypeⅠR-M系统在碳青霉烯耐药肺炎克雷伯菌流行中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:蒋晓飞
-
依托单位:
替加环素耐药基因 tet(A) type 1 变异体在碳青霉烯耐药肺炎克雷伯菌中的流行、进化和传播
-
批准号:LY22H200001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:蔡加昌
-
依托单位:
面向手性α-氨基酰胺药物的新型不对称Ugi-type 反应开发
-
批准号:LY22B020003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:李绍玉
-
依托单位: